Research Article
Congestive Heart Failure with Atrial Fibrillation
Laxmi Narayan Goit1,✉ and Yang Shaning2
1. Department of Cardiology, The First affiliated Hospital of Yangtze University, Jingzhou, Hubei, P.R China. 2. Department of Cardiology, The Clinical College of Yangtze University and the first affiliated hospital to Yangtze University, Jingzhou, Hubei, P.R china. ✉ Corresponding author Laxmi Narayan Goit, Department of Cardiology, The First affiliated Hospital of Yangtze University, Jingzhou, Hubei 434023, China. Email: [email protected]. Telephone number: +8615272634003 or 009779842187350 Received: May 5, 2019; Accepted: April 13, 2019; Published online: June 7, 2020. Cite this paper: Laxmi Narayan Goit and Shaning Yang (2020) Congestive Heart Failure with Atrial Fibrillation. Global Journal of Life Sciences, 1(1): 34-48. https://naturescholars.com/gjls.010106. https://doi.org/10.46633/gjls.010106. Copyright© 2020 by Scholars Publishing, LLC.
Abstract
Atrial fibrillation (AF) in patients with heart failure is common and associated with an increased risk of stroke, heart failure hospitalizations and all causes mortality. AF is a common sustained arrhythmia in HF and primary related to atrial dilation and remodeling. Heart failure is a common co-morbidity in diabetes and patients with both conditions have particularly poor prognosis. Most clinical outcome trials investigating the effect of glucose lowering agent have excluded patient with heart failure. Patients with heart failure are frequently affected with AF and interrelation between these pathologies is complex. AF share same risk factors as heart failure. The exact causes of atrial fibrillation in HF are incompletely understood but data suggest that heart failure induced atrial fibrosis and atrial ionic remodeling are underlying abnormalities that facilitate atrial fibrillation. Therapeutic considerations for atrial fibrillation in patients with heart failure include risk factors modifications and guidelines directed medical therapy, anticoagulation, rate control and rhythm control. Although anticoagulation therapy and rhythm or rate control are the foundation of atrial fibrillation therapy. Here we report a case of 66 years old female patient diagnosed as a congestive heart failure with atrial fibrillation with type-2 Diabetes mellitus. This article will present some practical tips for managing heart failure.
Key word: Heart Failure, Atrial Fibrillations, Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptors Blockers, Beta Blockers.